These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 32124117)

  • 1. Non-steroidal anti-inflammatory drugs in the pathophysiology of vasospasms and delayed cerebral ischemia following subarachnoid hemorrhage: a critical review.
    Solar P; Mackerle Z; Joukal M; Jancalek R
    Neurosurg Rev; 2021 Apr; 44(2):649-658. PubMed ID: 32124117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients with Aneurysmal Subarachnoid Hemorrhage (HOMA): study protocol for a randomized controlled trial.
    Lin F; Li R; Chen Y; Yang J; Wang K; Jia Y; Han H; Hao Q; Shi G; Wang S; Zhao Y; Chen X
    Trials; 2024 Jun; 25(1):377. PubMed ID: 38863026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs for vasospasm after subarachnoid hemorrhage.
    Tallarico RT; Pizzi MA; Freeman WD
    Expert Opin Investig Drugs; 2018 Apr; 27(4):313-324. PubMed ID: 29600883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological Prevention of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
    Caylor MM; Macdonald RL
    Neurocrit Care; 2024 Feb; 40(1):159-169. PubMed ID: 37740138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Luzzi S; Bektaşoğlu PK; Doğruel Y; Güngor A
    Neurosurg Rev; 2024 Jul; 47(1):305. PubMed ID: 38967704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD; de Haan RJ; Vermeulen M; Roos YB
    Stroke; 2010 Jan; 41(1):e47-52. PubMed ID: 19875741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risks of nimodipine dose reduction during the high-risk period for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Ditz C; Matone MV; Schwachenwald B; Küchler J
    Neurosurg Rev; 2024 Jan; 47(1):37. PubMed ID: 38191859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicardipine Prolonged Release Implants for Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Akbik F; Waddel H; Jaja BNR; Macdonald RL; Moore R; Samuels OB; Sadan O
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106020. PubMed ID: 34365121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnesium sulfate in combination with nimodipine for the treatment of subarachnoid hemorrhage: a randomized controlled clinical study.
    Zhang C; Zhao S; Zang Y; Zhao W; Song Q; Feng S; Hu L; Gu F
    Neurol Res; 2018 Apr; 40(4):283-291. PubMed ID: 29540123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.
    Naraoka M; Matsuda N; Shimamura N; Asano K; Akasaka K; Takemura A; Hasegawa S; Ohkuma H
    J Cereb Blood Flow Metab; 2018 Jul; 38(7):1190-1198. PubMed ID: 28762878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of post-interventional antiplatelet therapy on angiographic vasospasm, delayed cerebral ischemia, and clinical outcome after aneurysmal subarachnoid hemorrhage: a single-center experience.
    Ditz C; Machner B; Schacht H; Neumann A; Schramm P; Tronnier VM; Küchler J
    Neurosurg Rev; 2021 Oct; 44(5):2899-2912. PubMed ID: 33492514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter to editor: Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia.
    Rizvi SVZ; Zaidi SMF
    Neurosurg Rev; 2024 Aug; 47(1):383. PubMed ID: 39085665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
    Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
    J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter to the editor: "Beyond nimodipine: Advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia".
    Chen G; Xu K
    Neurosurg Rev; 2024 Jul; 47(1):361. PubMed ID: 39060440
    [No Abstract]   [Full Text] [Related]  

  • 19. Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study.
    Muraoka S; Asai T; Fukui T; Ota S; Shimato S; Koketsu N; Nishizawa T; Araki Y; Saito R
    Neurosurg Rev; 2023 Aug; 46(1):195. PubMed ID: 37555872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.
    Smetana KS; Buschur PL; Owusu-Guha J; May CC
    Crit Care Nurs Q; 2020; 43(2):138-156. PubMed ID: 32084059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.